Back to Search

JAMES HERMILLER, MD

MD

Interventional Cardiology Physician

NPI: 1619943263IndividualAccepts Medicare

Specialties, Licenses & Credentials

Cardiovascular Disease Physician

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

01040151A(IN)
Interventional Cardiology PhysicianPrimary

Internal Medicine — Interventional Cardiology

Code: 207RI0011X

01040151A(IN)

CMS Specialties

PrimaryINTERVENTIONAL CARDIOLOGY

Additional

CARDIOVASCULAR DISEASE (CARDIOLOGY)

Education

OHIO STATE UNIVERSITY COLLEGE OF MEDICINE

Class of 1983

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort

NCT01106534COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (20)

Commentary: Bifurcations: the problem is the side branch.
PMID 17042097·J Invasive Cardiol·2006
8-other
Bifurcation intervention: keep it simple.
PMID 16446513·J Invasive Cardiol·2006
6-review
The StarClose Vascular Closure System: interventional results from the CLIP study.
PMID 17039508·Catheter Cardiovasc Interv·2006
4-observational
Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial.
PMID 15837245·J Am Coll Cardiol·2005
3-trial
Contemporary management of vein graft disease.
PMID 16079442·J Invasive Cardiol·2005
6-review
Clinical experience with a circumferential clip-based vascular closure device in diagnostic catheterization.
PMID 16204741·J Invasive Cardiol·2005
4-observational
Contemporary treatment of small-vessel disease.
PMID 15282417·J Invasive Cardiol·2004
8-other
Role of enoxaparin in the invasive management of the ACS patient.
PMID 14760189·J Invasive Cardiol·2004
8-other
Effects of stent sizing on endothelial and vessel wall stress: potential mechanisms for in-stent restenosis.
PMID 19299567·J Appl Physiol (1985)·2009
8-other
Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
PMID 19171853·Circulation·2009
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
10590 N MERIDIAN ST
CARMEL, IN 46290

Quick Facts

NPI
1619943263
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
43
Clinical Trials
1
Publications
20

Are you this provider?

Claim Your Profile